I
Inovio Pharmaceuticals, Inc. (INO)
NCM – Real vaqt narxi. Valyuta: USD
1.10
+0.02 (1.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.09
-0.01 (-0.91%)
Bozordan keyin: Jun 26, 2026, 7:54 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.10
+0.02 (1.85%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
1.09
-0.01 (-0.91%)
Bozordan keyin: Jun 26, 2026, 7:54 PM EDT
This stock has a consensus price target of $15.31 based on the ratings of 8 analysts. The high is $40.00 and the low is $2.50.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 2.5 | $ 15.31 | $ 40 |
| O’zgarish | 125.23% | 1279.28% | 3503.60% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-06-01 | 124.22% | HC Wainwright & Co. | $3 → $2.5 | Maintains | Neutral |
| 2025-11-14 | 438.12% | Piper Sandler | $5 → $6 | Reiterates | Overweight |
| 2025-08-14 | 169.06% | HC Wainwright & Co. | $3 → $3 | Reiterates | Neutral |
| 2025-07-09 | 348.43% | Piper Sandler | $5 | Initiates Coverage On | Overweight |
| 2025-05-14 | 348.43% | RBC Capital | $5 → $5 | Reiterates | Sector Perform |